• OTS
  • January 31, 2018
SHARE
Post Views: 865

Liu H, Mai J, Shen J, Wolfram J, Li Z, Zhang G, Xu R, Li Y, Mu C, Zu Y, Li X, Lokesh GL, Thiviyanathan V, Volk DE, Gorenstein DG, Ferrari M, Hu Z, Shen H.
Theranostics. 2018 Jan 1;8(1):31-44.

PubMed

Related articles

How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands

How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands

April 23rd, 2021
Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation

Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation

April 23rd, 2021
Hovlinc is a recently evolved class of ribozyme found in human lncRNA

Hovlinc is a recently evolved class of ribozyme found in human lncRNA

April 23rd, 2021
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown

Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown

April 23rd, 2021
Super-resolution RNA imaging using a rhodamine-binding aptamer with fast exchange kinetics

Super-resolution RNA imaging using a rhodamine-binding aptamer with fast exchange kinetics

March 15th, 2021
A self-catabolic multifunctional DNAzyme nanosponge for programmable drug delivery and efficient gene silencing

A self-catabolic multifunctional DNAzyme nanosponge for programmable drug delivery and efficient gene silencing

March 15th, 2021